Retension Pharmaceuticals adopts amended and restated bylaws ahead of IPO close
RTSN•Retension Pharmaceuticals adopted amended and restated bylaws that took effect immediately before its IPO closed on Oct. 13, 2026. The company also filed a third amended and restated certificate of incorporation in Delaware on Oct. 9.
1. Bylaws take effect
Retension Pharmaceuticals adopted amended and restated bylaws, authorized by its board and stockholders, that took effect immediately before its IPO closed on Oct. 13, 2026. The company filed a third amended and restated certificate of incorporation in Delaware on Oct. 9.
